CH408283A - Reagens zur Kontrolle der Gerinnbarkeit des Blutes und seine Herstellung - Google Patents

Reagens zur Kontrolle der Gerinnbarkeit des Blutes und seine Herstellung

Info

Publication number
CH408283A
CH408283A CH7286559A CH7286559A CH408283A CH 408283 A CH408283 A CH 408283A CH 7286559 A CH7286559 A CH 7286559A CH 7286559 A CH7286559 A CH 7286559A CH 408283 A CH408283 A CH 408283A
Authority
CH
Switzerland
Prior art keywords
coagulability
reagent
blood
preparation
controlling
Prior art date
Application number
CH7286559A
Other languages
English (en)
Inventor
Paul Arnor Prof Dr Med Owren
Original Assignee
Paul Arnor Prof Dr Med Owren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Arnor Prof Dr Med Owren filed Critical Paul Arnor Prof Dr Med Owren
Publication of CH408283A publication Critical patent/CH408283A/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • G01N2496/05Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CH7286559A 1958-05-16 1959-05-04 Reagens zur Kontrolle der Gerinnbarkeit des Blutes und seine Herstellung CH408283A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO12810458 1958-05-16

Publications (1)

Publication Number Publication Date
CH408283A true CH408283A (de) 1966-02-28

Family

ID=19908436

Family Applications (1)

Application Number Title Priority Date Filing Date
CH7286559A CH408283A (de) 1958-05-16 1959-05-04 Reagens zur Kontrolle der Gerinnbarkeit des Blutes und seine Herstellung

Country Status (7)

Country Link
US (1) US3179567A (de)
CH (1) CH408283A (de)
DE (1) DE1189763B (de)
ES (1) ES249137A1 (de)
FR (1) FR1223856A (de)
GB (1) GB917012A (de)
NL (2) NL123584C (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293134A (en) * 1961-09-08 1966-12-20 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
US3486981A (en) * 1965-03-15 1969-12-30 Roy E Speck Substances relating to testing of blood-coagulation
US3228841A (en) * 1965-06-10 1966-01-11 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3880714A (en) * 1973-07-18 1975-04-29 Warner Lambert Co Diagnostic reagent
US3947378A (en) * 1974-12-23 1976-03-30 Warner-Lambert Company Adsorbed plasma
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4038147A (en) * 1976-06-15 1977-07-26 Becton, Dickinson And Company Method for detecting endotoxins
DE2915310A1 (de) * 1979-04-14 1980-10-30 Behringwerke Ag Neues partielles thromboplastin und dessen verwendung
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
AU744287B2 (en) * 1990-11-13 2002-02-21 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6203816B1 (en) * 1990-11-13 2001-03-20 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー 凍結乾燥方法
JP7471316B2 (ja) 2019-03-14 2024-04-19 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー マルチパート凍結乾燥容器
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687980A (en) * 1948-09-15 1954-08-31 Ernest W Blanchard Thromboplastin product and method for preparing same
US2847350A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Preparation of highly active thromboplastin

Also Published As

Publication number Publication date
ES249137A1 (es) 1959-11-16
NL123584C (de)
DE1189763B (de) 1965-03-25
NL238873A (de)
US3179567A (en) 1965-04-20
FR1223856A (fr) 1960-06-21
GB917012A (en) 1963-01-30

Similar Documents

Publication Publication Date Title
CH408283A (de) Reagens zur Kontrolle der Gerinnbarkeit des Blutes und seine Herstellung
CH423793A (de) Verfahren zur Herstellung von 1-Alkyl- und 1-Alkenylbenzimidazolen
CH427353A (de) Stabilisierte Mischung zum Nachweis von Blut
AT278354B (de) Verfahren zur Herstellung von Homopolymeren und Copolymeren von Methylmethacrylat
CH411921A (de) Verfahren zur Herstellung von Aminoacetonitrilen
CH403343A (de) Flüssigkeitstrennwand und Verfahren zur Herstellung derselben
CH419434A (de) Kunstfaden und Verfahren zur Herstellung desselben
CH387457A (de) Einrichtung zur automatischen Behandlung von Flüssigkeiten für Analysen oder andere Zwecke
DE1068428C2 (de) Verfahren und Einrichtung zur Herstellung von oxygeniertrm Blut
CH372170A (de) Vorrichtung zur Herstellung von Folienschallplatten
AT227884B (de) Mittel zur Behandlung schwefelhaltiger Skleroproteine
CH417965A (de) Verfahren zur Herstellung von Heteroblock-Copolymeren
CH397677A (de) Verfahren zur Herstellung von Aroylalkylpiperidinen
CH377331A (de) Verfahren zur Herstellung von O,O-Dialkylphosphor- oder O,O-Dialkylthionophosphorsäureestern substituierter Butenole
CH420821A (de) Würzmittel und Verfahren zur Herstellung desselben
CH388321A (de) Verfahren zur Herstellung von 6-Chlor-tri-O-acyl-B-D-ribofuranosyl-purin oder seines 2-Aminoderivates
CH377839A (de) Verfahren zur Herstellung von a-Phenylbenzoyl-a-arylaminocarbinolderivaten
AU252524B1 (en) Preservation of biological substances
CH380675A (de) Verfahren und Vorrichtung zur Herstellung von Zuckerpresslingen
CH409984A (de) Festes, feinverteiltes Cyanurchlorid, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung von Aminochlortriazinen
CH371446A (de) Verfahren zur Herstellung von 6a,16a-Dimethylprogesteron
CH371445A (de) Verfahren zur Herstellung von 3-Oxo- 1,4-und 3-Oxo- 1,4,6-steroiden
CH387645A (de) Verfahren zur Herstellung von Rhodantriazinen
CH383960A (de) Verfahren zur Herstellung von gonadenhemmenden Derivaten des 17-epi-Oestriols
CH394229A (de) Verfahren zur Herstellung von 3-Aralkyl-2-tert.-aminoalkyl-indenen